| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Revenue | $1.17B | +7.3% |
| Cost of Revenue | $615.0M | +8.8% |
| R&D Expense | $143.2M | +3.8% |
| SG&A Expense | $247.6M | +4.0% |
| Operating Income | $123.9M | +57.3% |
| Pre-tax Income | $92.4M | +51.9% |
| Income Tax | $26.1M | +56.1% |
| Net Income | $66.2M | +50.4% |
| EPS (Basic) | $2.21 |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $186.3M | +23.9% |
| Short-term Investments | $0 | -100.0% |
| Accounts Receivable | $267.7M | -2.4% |
| Current Assets | $862.2M | +12.6% |
| Total Assets | $1.44B | +7.0% |
| Current Liabilities | $560.8M | +6.4% |
| Long-term Debt | $542.5M | +31.4% |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $131.9M | +107.4% |
| Capital Expenditures | $28.0M | -24.4% |
| Investing Cash Flow | -$27.9M | -208.8% |
| Financing Cash Flow | -$31.3M | +39.4% |
| Free Cash Flow | $103.9M | +290.6% |
| +55.6% |
| EPS (Diluted) | $2.20 | +56.0% |
| Total Liabilities |
| $1.17B |
| +17.8% |
| Stockholders' Equity | $273.3M | -23.1% |